
MiMedx Group MDXG
$ 3.65
1.11%
Quarterly report 2026-Q1
added 04-29-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
148 M |
Market Cap[1] |
$ 539 M |
EBITDA (LTM) |
$ 17.6 M |
P/E (LTM) |
33.6 |
P/S (LTM) |
1.51 |
EPS (LTM) |
0.1 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.18 | 0.93 % | $ 1.33 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 11.09 | 0.64 % | $ 397 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.56 | -0.23 % | $ 216 M | NYSE American | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.49 | 4.49 % | $ 131 M | Nasdaq Global Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 46.07 | -16.05 % | $ 1.35 B | NYSE,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 11.01 | -1.52 % | $ 312 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 58.97 | -0.18 % | $ 3.22 B | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.62 | -0.02 % | $ 38.6 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.06 | -2.3 % | $ 18 M | Nasdaq Global Select Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.78 | - | $ 370 M | Nasdaq Global Select Market,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.38 | -1.65 % | $ 6.6 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 4.97 | 2.58 % | $ 1.05 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 90.18 | -0.46 % | $ 12.2 B | NYSE,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 36.28 | 1.03 % | $ 1.13 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 83.51 | -0.6 % | $ 2.9 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 96.22 | -0.89 % | $ 3.27 B | Nasdaq Global Market | ||
|
Stryker Corporation
SYK
|
$ 291.43 | 0.2 % | $ 111 B | NYSE,SPB | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.16 | -3.59 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 82.17 | -1.4 % | $ 48.1 B | NYSE,SPB | ||
|
LENSAR
LNSR
|
$ 5.51 | -0.9 % | $ 65.9 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.32 | -0.75 % | $ 53.7 M | Nasdaq Global Select Market | ||
|
Myomo
MYO
|
$ 0.86 | - | $ 36 M | NYSE American | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.